期刊簡介預計審稿時間： 10 Weeks

MedComm is a peer-reviewed, online open access journal that publishes the pioneer works providing novel insights into all aspects of medicine on the basis of novelty, timeliness and significance to human health. The journal emphasizes original findings that advance the understanding of pathogenesis or improve the diagnosis and treatment of human disease. Interdisciplinary studies utilizing approaches of molecular biology, cell biology, chemistry, pharmacology or material science to address the issues of clinical, basic and translational medicines are particularly encouraged. MedComm is interested in topics including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology and artificial intelligence. The journal focuses on clinical and experimental advances on disease characteristics, pathogenic mechanism and medical techniques.

MedComm是同行評審的在線開放獲取期刊，及時發(fā)表具有新穎性的、對人類健康有重要意義的開創(chuàng)性醫(yī)學研究。該期刊重視原創(chuàng)性發(fā)現(xiàn)，旨在促進對發(fā)病機制的理解及改善對人類疾病的診斷與治療，尤其青睞利用分子生物學、細胞生物學、化學、藥理學或材料科學方法解決臨床、基礎和轉化醫(yī)學問題的跨學科研究。MedComm關注的主題包括但不限于臨床醫(yī)學、分子診斷、表觀遺傳學/遺傳學、細胞生物學、藥物發(fā)現(xiàn)、進化醫(yī)學、納米技術和人工智能。該期刊聚焦疾病特征、致病機制和醫(yī)學技術的臨床與實驗進展。

如果您需要協(xié)助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發(fā)表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。